Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCPVax in Glioblastoma
NCT04280848Phase 2Completed
- Sponsor
- CHU de Besançon
- Start
- May 2020
- Primary completion
- Dec 2023
- Modality
- Peptides, Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of UCPVax in glioblastoma (GBM), sponsored by CHU de Besançon. Started May 2020; status: completed.
02
Drugs
UCPVax
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT04280848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04280848.